Literature DB >> 10416890

Disc position and morphology in patients with nonreducing disc displacement treated by injection of sodium hyaluronate.

S Sato1, M Sakamoto, H Kawamura, K Motegi.   

Abstract

Disc position and morphology were examined in 21 patients (22 joints) with nonreducing disc displacement of the temporomandibular joint (TMJ) at more than 12 months after undergoing injection of sodium hyaluronate into the superior joint space. The patients' clinical signs and symptoms improved during the follow-up period. In all patients, the disc was displaced anteriorly on mouth closure and did not reduce into the normal position during mouth opening at follow-up, whereas a normal disc position was found in all the controls. In the patients, the disc deviated from the normal biconcave configuration found in all of the controls on the follow-up magnetic resonance imaging (MRI). Disc displacement apparently is persistent and continued disc deformity common in patients, although the clinical signs and symptoms improved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416890

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  3 in total

Review 1.  Emerging intra-articular drug delivery systems for the temporomandibular joint.

Authors:  Paschalia M Mountziaris; Phillip R Kramer; Antonios G Mikos
Journal:  Methods       Date:  2008-10-01       Impact factor: 3.608

2.  Differences Regarding Branded HA in Italy, Part 2: Data from Clinical Studies on Knee, Hip, Shoulder, Ankle, Temporomandibular Joint, Vertebral Facets, and Carpometacarpal Joint.

Authors:  A Migliore; E Bizzi; O De Lucia; A Delle Sedie; S Tropea; M Bentivegna; A Mahmoud; C Foti
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-06-07

3.  Magnetic resonance imaging of temporomandibular joint with anterior disk dislocation without reposition - long-term results.

Authors:  M Bristela; M Schmid-Schwap; J Eder; G Reichenberg; M Kundi; E Piehslinger; S Robinson
Journal:  Clin Oral Investig       Date:  2016-04-16       Impact factor: 3.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.